Related Experiment Videos
KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer
Seungjae Shin1, Seung-Pyo Hong1, Seoho Lee1
1Seoul National University College of Medicine Seoul Korea (South), Republic of.
Cancer Research
|July 29, 2026
Summary
KRAS mutations in colorectal cancer (CRC) promote immune evasion by altering RNA methylation (m6A). Targeting METTL3 restores antitumor immunity and improves immunotherapy response in KRAS-mutant CRC.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- KRAS mutations are common in colorectal cancer (CRC), correlating with an immunosuppressive tumor microenvironment and poor immunotherapy outcomes.
- This immunosuppression is characterized by limited immune cell infiltration and reduced efficacy of cancer treatments.
Purpose of the Study:
- To investigate how KRAS mutations influence the tumor microenvironment and immune evasion in CRC.
- To identify molecular mechanisms underlying KRAS-driven immune suppression.
- To explore potential therapeutic targets for overcoming resistance in KRAS-mutant CRC.
Main Methods:
- Methylated RNA immunoprecipitation sequencing (MeRIP-seq) to analyze m6A modifications in KRAS-mutant CRC cells.
- Investigated the role of IGF2BP3 in stabilizing CD73 mRNA.
- Assessed the function of TEAD4 in recruiting the METTL3 methyltransferase complex.
- Utilized syngeneic tumor models with METTL3 knockdown and combination therapies (anti-PD-1, CD73 inhibitor).
Main Results:
- KRAS mutations were found to remodel the N6-methyladenosine (m6A) epitranscriptome, promoting immune evasion.
- Increased m6A deposition on CD73 mRNA was observed in KRAS-mutant cells, enhancing mRNA stability via IGF2BP3.
- TEAD4 was identified as a spatial regulator of m6A deposition by recruiting the METTL3 complex.
- METTL3 inhibition in KRAS-mutant tumors suppressed growth, increased CD8+ T-cell and NK-cell infiltration, and synergized with anti-PD-1 and CD73 inhibitors.
Conclusions:
- KRAS-driven m6A RNA modifications are a critical mechanism of immune suppression in colorectal cancer.
- METTL3 plays a key role in mediating KRAS-driven immune evasion by regulating CD73 expression.
- METTL3 inhibition represents a promising therapeutic strategy for KRAS-mutant CRC, potentially enhancing immunotherapy efficacy.
Related Concept Videos
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...